Clinical Study of the Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in People Aged 65 Years or Older

NCT00765076 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

192

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: GSK Biologicals' influenza vaccine GSK2186877A
BIOLOGICAL: GSK Biologicals' Fluarix

Sponsor

GlaxoSmithKline